Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
0.274
-0.007 (-2.32%)
Jul 22, 2024, 10:07 AM EDT - Market open
Lyra Therapeutics Employees
Lyra Therapeutics had 88 employees as of December 31, 2023. The number of employees increased by 30 or 51.72% compared to the previous year.
Employees
88
Change (1Y)
30
Growth (1Y)
51.72%
Revenue / Employee
$19,091
Profits / Employee
-$782,693
Market Cap
16.64M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 88 | 30 | 51.72% |
Dec 31, 2022 | 58 | 5 | 9.43% |
Dec 31, 2021 | 53 | 15 | 39.47% |
Dec 31, 2020 | 38 | 0 | - |
Dec 31, 2019 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
VBI Vaccines | 138 |
Kindly MD | 65 |
Biotricity | 55 |
Sensei Biotherapeutics | 28 |
Microbot Medical | 22 |
Aeterna Zentaris | 12 |
Synlogic | 6 |
Aptorum Group | 3 |
LYRA News
- 2 months ago - Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital - GlobeNewsWire
- 2 months ago - Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis - GlobeNewsWire
- 2 months ago - Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 months ago - Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 months ago - Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - Lyra Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire